OmniAb (OABI) Non-Current Deffered Revenue (2021 - 2026)
OmniAb's (OABI) quarterly Non-Current Deffered Revenue came in at $400000.0 in Q1 2026, up 852.38% on a QoQ basis from $42000.0 in Q2 2025.
OmniAb (OABI) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Non-Current Deffered Revenue data on file, last reported at $400000.0 in Q1 2026.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $400000.0 in Q1 2026; TTM through Mar 2026 was $400000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $117000.0, down 86.43% from the prior year.
- Non-Current Deffered Revenue for Q1 2026 stood at $400000.0, up from $42000.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for OABI reached as high as $4.3 million in Q4 2022 and fell as low as $41000.0 in Q3 2024.
- Historically, Non-Current Deffered Revenue has averaged $1.3 million across 5 years, with a median of $400000.0 in 2026.
- Across the five-year window, Non-Current Deffered Revenue slumped 97.93% in 2024 and tumbled 41.67% in 2025, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $4.3 million in 2022, then plunged by 80.07% to $862000.0 in 2023, then tumbled by 86.43% to $117000.0 in 2024, then sank by 64.1% to $42000.0 in 2025, then jumped by 852.38% to $400000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $400000.0 in Q1 2026, $42000.0 in Q2 2025, and $117000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Dec 31, 2024 | 117,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 72,000.00 |
| Mar 31, 2024 | 279,000.00 |
| Dec 31, 2023 | 862,000.00 |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 3.48 Mn |
| Mar 31, 2023 | 3.02 Mn |
| Dec 31, 2022 | 4.33 Mn |
| Dec 31, 2021 | 9.23 Mn |